Key facts: Netherlands
| Main buyers | Health insurers for outpatient medicines; hospitals and hospital purchasing groups for inpatient and specialist medicines |
|---|---|
| Main routes | Insurer preference policy (selection rounds, not public tenders); university hospital tenders; negotiated hospital contracts |
| Typical term | Usually two years for preference designations; hospital contracts vary |
| Award model | Lowest price for preference policy; hospital tenders often multi-criteria |
How do Dutch insurers choose generics?
Each major insurer runs its own preference policy. It invites offers per active ingredient and designates the preferred product, usually the lowest priced, for a set period. Because a handful of insurers cover most of the population, winning a round with a large insurer moves significant volume.
Since 2025 insurers stagger their start dates and can lift preference status when a shortage threatens, and parliament voted to keep critical and low-turnover medicines out of the policy. An evaluation of the policy is due at the end of 2026.
How do Dutch hospitals buy?
Most general hospitals are not bound by public procurement law, so they buy specialist and inpatient medicines through negotiated contracts and purchasing collaborations. University medical centres are contracting authorities and publish their tenders.
Aanbesteding, gunning and the preferentiebeleid
For outpatient generics there is no classic aanbesteding: insurers run selection rounds under the preferentiebeleid and publish the preferred products. Prices and bids stay private.
University medical centres do run a Europese aanbesteding for medicines, and the gunning, the award decision, names the winning supplier. The hospital pharmacy (ziekenhuisapotheek) decides which product is used, so the gunning and actual use can differ.
How does RGS help in the Netherlands?
We track insurer preference lists and university hospital tenders together, so you see both the outpatient and the hospital side of a molecule, and we estimate the real patient volume behind each contract.
What is public in Netherlands, and what is not
Insurers publish which products are preferred, and university hospital tenders are published.
Preference prices and the bids in each selection round are never published, general hospital contracts are not published at all, and national price arrangements for expensive hospital medicines are largely confidential discounts.
Questions about Netherlands
Is the Dutch preference policy a public tender?
No. Insurers run their own selection rounds, which work like tenders but are not published as public procurement. The resulting lists of preferred products are public; the prices are not.
Do Dutch hospitals have to tender medicines publicly?
Only university medical centres. Most general hospitals are not contracting authorities, so their medicine contracts are negotiated and not published.
Is there a public aanbesteding for generic medicines in the Netherlands?
Not for outpatient generics. Insurers select preferred products through their own rounds under the preferentiebeleid. Public aanbestedingen with a published gunning are run mainly by university medical centres.
Can RGS show confidential contracts and prices in Netherlands?
No outside service can, because they are never published. RGS covers what buyers publish. For the confidential part we set up a private pipeline for your company: your own bids, results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.